These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 33590521)

  • 61. Economics of polio vaccination in the post-eradication era: should OPV-using countries adopt IPV?
    Khan MM
    Vaccine; 2008 Apr; 26(16):2034-40. PubMed ID: 18339460
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Safe landing for global polio eradication: a perspective.
    Arita I; Francis DP
    Vaccine; 2011 Nov; 29(48):8827-34. PubMed ID: 21959326
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Transition Planning For After Polio Eradication.
    Rutter PD; Hinman AR; Hegg L; King D; Sosler S; Swezy V; Hussey AL; Cochi SL
    J Infect Dis; 2017 Jul; 216(suppl_1):S287-S292. PubMed ID: 28838183
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Characterising the costs of the Global Polio Laboratory Network: a survey-based analysis.
    Duintjer Tebbens RJ; Diop OM; Pallansch MA; Oberste MS; Thompson KM
    BMJ Open; 2019 Jan; 9(1):e023290. PubMed ID: 30670511
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Progress Toward Polio Eradication - Worldwide, January 2018-March 2020.
    Chard AN; Datta SD; Tallis G; Burns CC; Wassilak SGF; Vertefeuille JF; Zaffran M
    MMWR Morb Mortal Wkly Rep; 2020 Jun; 69(25):784-789. PubMed ID: 32584798
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.
    Orenstein WA;
    Pediatrics; 2015 Jan; 135(1):196-202. PubMed ID: 25548328
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Economic impact of introducing the injectable inactivated polio vaccine in Colombia].
    Alvis N; De la Hoz F; Narváez J
    Rev Panam Salud Publica; 2010 May; 27(5):352-9. PubMed ID: 20602069
    [TBL] [Abstract][Full Text] [Related]  

  • 68. National introduction of fractional-dose inactivated polio vaccine in Sri Lanka following the global "switch".
    Gamage D; Ginige S; Palihawadana P
    WHO South East Asia J Public Health; 2018 Sep; 7(2):79-83. PubMed ID: 30136665
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Budget impact of polio immunization strategy for India: introduction of one dose of inactivated poliomyelitis vaccine and reductions in supplemental polio immunization.
    Khan MM; Sharma S; Tripathi B; Alvarez FP
    Public Health; 2017 Jan; 142():31-38. PubMed ID: 28057194
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Financial Support to Eligible Countries for the Switch From Trivalent to Bivalent Oral Polio Vaccine-Lessons Learned.
    Shendale S; Farrell M; Hampton LM; Harris JB; Kachra T; Kurji F; Patel M; Ramirez Gonzalez A; Zipursky S
    J Infect Dis; 2017 Jul; 216(suppl_1):S57-S65. PubMed ID: 28838171
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Current polio global eradication and control policy options: perspectives from modeling and prerequisites for oral poliovirus vaccine cessation.
    Thompson KM; Tebbens RJ
    Expert Rev Vaccines; 2012 Apr; 11(4):449-59. PubMed ID: 22551030
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Current status of the global eradication of poliomyelitis.
    Tangermann RH; Aylward B; Birmingham M; Horner R; Olivé JM; Nkowane BM; Hull HF; Burton A
    World Health Stat Q; 1997; 50(3-4):188-94. PubMed ID: 9477548
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The global polio eradication initiative Stop Transmission of Polio (STOP) program - 1999-2013.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Jun; 62(24):501-3. PubMed ID: 23784015
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Innovation for polio eradication.
    Lancet Infect Dis; 2011 Oct; 11(10):721. PubMed ID: 21958571
    [No Abstract]   [Full Text] [Related]  

  • 75. Measles and rubella elimination: learning from polio eradication and moving forward with a diagonal approach.
    Goodson JL; Alexander JP; Linkins RW; Orenstein WA
    Expert Rev Vaccines; 2017 Dec; 16(12):1203-1216. PubMed ID: 29037086
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Geographic information system and information visualization capacity building: Successful polio eradication and current and future challenges in the COVID-19 era for the World Health Organization's African region.
    Kipterer JK; Touray K; Godwin AU; Cisse A; Aimee BNM; Busisiwe N; Derrick CYD; Henry GH; Modjirom N; Seaman V; Ahmed J
    PLoS One; 2024; 19(8):e0307001. PubMed ID: 39146252
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inactivated polio vaccine: its proposed role in the final stages of polio eradication.
    Davis R; Biellik R
    Pan Afr Med J; 2013; 14():102. PubMed ID: 23717717
    [No Abstract]   [Full Text] [Related]  

  • 78. Oral polio vaccine response in the MAL-ED birth cohort study: Considerations for polio eradication strategies.
    Pan WK; Seidman JC; Ali A; Hoest C; Mason C; Mondal D; Knobler SL; Bessong P;
    Vaccine; 2019 Jan; 37(2):352-365. PubMed ID: 30442479
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Global polio eradication initiative: lessons learned and legacy.
    Cochi SL; Freeman A; Guirguis S; Jafari H; Aylward B
    J Infect Dis; 2014 Nov; 210 Suppl 1(Suppl 1):S540-6. PubMed ID: 25316878
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Polio eradication: next steps and future challenges.
    Zambon M; Martin J
    Euro Surveill; 2018 Nov; 23(47):. PubMed ID: 30482261
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.